It is currently Mon Nov 24, 2014 4:42 am

News News of ThisIsMS

Site map of ThisIsMS » Forum : ThisIsMS

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

how much are you paying for Tysabri?

My friend is DESPERATELY trying to get his Ty. Been approved by TOUCH, but has a $%&**^%$ Neuro, in my opinion. A long story, but I will condense. He dropped his Medicare supplement because of price. Had to get it back because Neuro wouldn't consider Ty without it. Now, after MUCH run around, the place that would take his Medicare Part B and the Blue Cross Blue Shield Supplement, wants $500.00 up front each visit. ...
Read more : how much are you paying for Tysabri? | Views : 2260 | Replies : 3 | Forum : Tysabri (Antegren or Natalizumab)


MS linked to Mono

http://www.reutershealth.com/en/index.html

Last Updated: 2007-01-09 15:20:40 -0400 (Reuters Health)

NEW YORK (Reuters Health) - Individuals who have had infectious mononucleosis have an increased risk of developing
multiple sclerosis (MS), even 30 years after infection, according to findings published in the Archives of Neurology.

While "mono" has been linked with MS before, "little is known about the characteristics of this association,"
write Dr. Trine Rasmussen Nielsen, of Statens Serum Institut, Copenhagen, ...
Read more : MS linked to Mono | Views : 3258 | Replies : 23 | Forum : General Discussion


Brief Campath update

A blurb about Campath from a Genzyme press release today:



Following an encouraging meeting with the FDA in November, Genzyme expects to initiate during the first half of this year a phase 3 study of alemtuzumab (Campath) for the treatment of relapsing/remitting multiple sclerosis. The company is currently developing the study protocol to submit to the agency for review. Two-year results from a pre-planned interim analysis of the three-year phase 2 study were released in ...
Read more : Brief Campath update | Views : 1374 | Replies : 3 | Forum : Drug Pipeline


Immune system and the small intestine

Interesting. I had to find something to lift my spirits after reading all of Dignan's depressing house cleaning over on the pipeline :lol:

Why doesn't the immune system attack the small intestine?

Answering one of the oldest questions in human physiology, researchers at Dana-Farber Cancer Institute have discovered why the body's immune system - perpetually on guard against foreign microbes like bacteria – doesn't attack tissues in ...
Read more : Immune system and the small intestine | Views : 927 | Replies : 0 | Forum : General Discussion


Attn: Jimmylegs Re: Uric Acid

Hey,
I just ran across this on another newsgroup and I was wondering if you had any thoughts you might be able to share on the subject?
    Serum uric Acid and cognitive function in community-dwelling older adults. Neuropsychology. 2007 Jan;21(1):136-40.

    Among possible markers of age-related cognitive decline, uric acid (UA) is controversial because it has antioxidant properties but is increased in diseases that often lead to cognitive impairment. In this study of 96 elderly adults, ...
Read more : Attn: Jimmylegs Re: Uric Acid | Views : 2141 | Replies : 13 | Forum : General Discussion


New recommendation for advised intake of vitamin D

Risk assessment for vitamin D

John N Hathcock, Andrew Shao, Reinhold Vieth, and Robert Heaney

ABSTRACT

The objective of this review was to apply the risk assessment methodology
used by the Food and Nutrition Board (FNB) to derive a revised safe Tolerable Upper Intake Level (UL) for vitamin D.

New data continue to emerge regarding the health benefits of vitamin Dbeyond its role in bone. The intakes associated with those benefits suggest a need for ...
Read more : New recommendation for advised intake of vitamin D | Views : 966 | Replies : 1 | Forum : General Discussion


Article on lack of new drugs

Found this to be interesting and somewhat "encouraging":

http://www.msnbc.msn.com/id/16488678/
Read more : Article on lack of new drugs | Views : 767 | Replies : 0 | Forum : General Discussion


BG 12 Phase III

Biogen Idec Initiates Phase III Clinical Program of Oral Compound BG-12 for Multiple Sclerosis

Biogen Idec announced today that it has initiated the Phase III clinical program of BG-12, an oral fumarate in development for relapsing-remitting multiple sclerosis (MS).

The DEFINE (determination of the efficacy and safety of oral fumarate in relapsing-remitting MS) and CONFIRM (comparator and an oral fumarate in relapsing-remitting MS) studies will include more than 2,000 total patients in North America, ...
Read more : BG 12 Phase III | Views : 1506 | Replies : 0 | Forum : Tecfidera (BG-12, dimethyl fumarate)


Vaccine to Reverse the Effects of MS?

Hey all,

Has anyone seen this clip I received from WebMD? It talks about a new vacine called Neuro Vax. Has anyone heard of it or tried it?

http://www.webmd.com/content/pages/26/115077.htm?ecd=wnl_mls_010807
Read more : Vaccine to Reverse the Effects of MS? | Views : 2537 | Replies : 11 | Forum : General Discussion


further research on Amniotic stem cells

http://www.usatoday.com/tech/science/genetics/2007-01-07-stem-cells_x.htm?POE=TECISVA

The researchers at the Wake Forest University School of Medicine in Winston-Salem, N.C., were able to get the amniotic cells to differentiate into fat, bone, muscle, blood, nerve and liver cells.


One advantage is that these cells, unlike embryonic stem cells, don't form tumors when implanted into mice.
Isnt that just dandy for the mouse.

But even more important, because amniotic fluid is so easy to harvest, it would make it possible ...
Read more : further research on Amniotic stem cells | Views : 1479 | Replies : 2 | Forum : Stem Cells


 

Login  •  Register


Statistics

Total posts 221718 • Total topics 23018 • Total members 14546


Contact us | Terms of Service